The results of network pharmacology and molecular docking showed that quercetin, isorhamnetin, and kaempferol exerted their therapeutic effects on chronic bronchitis by blocking the Fc epsilon RI signaling pathway, mitogen-activated protein kinase signaling pathway, and vascular endothelial growth factor signaling pathway. The gene discussed is VEGFA; the disease is chronic bronchitis.